New pill targets hard-to-treat blood cancers in early trial
Disease control
Not yet recruiting
This early-phase study tests an experimental drug called MS-553 in 12 adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has returned or stopped responding to prior therapy. The main goal is to check safety and side effects. Participan…
Phase: PHASE1, PHASE2 • Sponsor: MingSight Pharmaceuticals, Inc • Aim: Disease control
Last updated May 22, 2026 14:03 UTC